NCT03587038 2025-12-10OKN-007 in Combination With Adjuvant Temozolomide Chemoradiotherapy for Newly Diagnosed GlioblastomaUniversity of OklahomaPhase 1 Active not recruiting27 enrolled
NCT04388475 2025-08-12Open-label Study Investigating of OKN-007 Combined With Temozolomide in Patients With Recurrent GlioblastomaOblato, Inc.Phase 2 Completed57 enrolled